Hims & Hers: Fear Surrounding GLP-1 Provides Another Opportunity

J Studios Introduction The telehealth company Hims & Hers (NYSE:HIMS) has seen its stock price range from under $6 to over $25 during the last 52 weeks. Since the stock price peaked in June, the stock has almost been cut in half. Back in May Hims surprised the market by announcing its affordable GLP-1 offering which immediately sent the stock soaring. However, recent news regarding Hims ability to continue with its GLP-1 offering beyond the temporary shortage has led to uncertainty around the stock. As of w ...